Renaissance Technologies
SNOA icon

Renaissance Technologies’s Sonoma Pharmaceuticals SNOA Stock Holding History

Renaissance Technologies’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,800
Closed -$50.6K – 3877
2025
Q2 		$50.6K Buy
+17,800
New +$53.8K ﹤0.01% 3391
2023
Q4 		– Sell
-700
Closed -$11K – 4102
2023
Q3 		$11K Sell
700
-410
-37% -$8.01K ﹤0.01% 3579
2023
Q2 		$24K Sell
1,110
-988
-47% -$20.3K ﹤0.01% 3742
2023
Q1 		$41K Sell
2,098
-1,625
-44% -$41.9K ﹤0.01% 3705
2022
Q4 		$83K Sell
3,723
-45
-1% -$1.6K ﹤0.01% 3680
2022
Q3 		$161K Sell
3,768
-20
-0.5% -$1.17K ﹤0.01% 3453
2022
Q2 		$221K Buy
3,788
+770
+26% +$49.3K ﹤0.01% 3610
2022
Q1 		$242K Sell
3,018
-95
-3% -$6.87K ﹤0.01% 3564
2021
Q4 		$284K Sell
3,113
-1,420
-31% -$152K ﹤0.01% 3365
2021
Q3 		$506K Sell
4,533
-75
-2% -$9.23K ﹤0.01% 2887
2021
Q2 		$677K Sell
4,608
-333
-7% -$52.3K ﹤0.01% 2835
2021
Q1 		$734K Buy
4,941
+354
+8% +$57.3K ﹤0.01% 2749
2020
Q4 		$666K Sell
4,587
-150
-3% -$22.8K ﹤0.01% 2701
2020
Q3 		$793K Buy
4,737
+625
+15% +$96.2K ﹤0.01% 2631
2020
Q2 		$586K Buy
4,112
+629
+18% +$75.6K ﹤0.01% 2812
2020
Q1 		$341K Buy
3,483
+548
+19% +$55.2K ﹤0.01% 2922
2019
Q4 		$256K Buy
2,935
+611
+26% +$61K ﹤0.01% 3111
2019
Q3 		$268K Buy
2,324
+369
+19% +$47.6K ﹤0.01% 3066
2019
Q2 		$310K Buy
1,955
+454
+30% +$69.7K ﹤0.01% 3164
2019
Q1 		$254K Buy
1,501
+455
+43% +$68.8K ﹤0.01% 3146
2018
Q4 		$134K Buy
1,046
+357
+52% +$71.2K ﹤0.01% 3195
2018
Q3 		$181K Buy
689
+183
+36% +$66.5K ﹤0.01% 3170
2018
Q2 		$226K Buy
506
+179
+55% +$117K ﹤0.01% 3049
2018
Q1 		$217K Buy
327
+1
+0.3% +$822 ﹤0.01% 3163
2017
Q4 		$319K Buy
326
+121
+59% +$104K ﹤0.01% 3007
2017
Q3 		$193K Sell
205
-13
-6% -$14.1K ﹤0.01% 3006
2017
Q2 		$260K Sell
218
-30
-12% -$37K ﹤0.01% 2937
2017
Q1 		$320K Buy
248
+172
+226% +$200K ﹤0.01% 2892
2016
Q4 		$69K Buy
+76
New +$63K ﹤0.01% 3137

Other funds holding SNOA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's SNOA Position: Q3 2025 in Review

Renaissance Technologies sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2025, closing a stake of 17,800 shares — an estimated $50.6K sold.

Renaissance Technologies first reported a position in SNOA in Q4 2016 and held it in 29 quarters. The position peaked at $793K in Q3 2020. 20 funds tracked by Wall St. Rank hold SNOA as of Q3 2025.

  • Renaissance Technologies reported no remaining Sonoma Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 17,800 Sonoma Pharmaceuticals shares in Q3 2025, an estimated $50.6K.
  • Renaissance Technologies first reported a position in Sonoma Pharmaceuticals in Q4 2016 and held it in 29 quarters.
  • Renaissance Technologies's Sonoma Pharmaceuticals position peaked at $793K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.